Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Holding people accountable

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Aug 03, 2023 3:25pm

56 Views

Post# 35571903

RE:Holding people accountable

Short summary in French of your post
" Les bottines de Paul ne semblent pas avoir suivies ses babines"

Johnnycash23 wrote: Some may recall the first conference call hosted by PL when he was brought in as the savior. He then strongly and pretentiously declared that he would be holding people accountable based on results. I guess he was not including himself...
Tesamorelin in Nash?
Oncology (how do you commit to a clinical trial without money to finance it?)
Partnerships with Chinese company?
sales growth (other than price increases)?
share price?
Europe?
Business development (marketing agreement, etc.)?